Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside their companies to offer listeners diverse perspectives from experts across niches and levels in the biotech space. On Inside Biotech, science story-telling meets big business, touching on a range of themes from across the world of southern California’s biotechnology industry.
All content for Inside Biotech is the property of Gabriella Rubert, Daniel Arce, Katherine Merkling, Serena Gao, Bryan Jimenez, Danielle Luu, Stephanie Wu and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside their companies to offer listeners diverse perspectives from experts across niches and levels in the biotech space. On Inside Biotech, science story-telling meets big business, touching on a range of themes from across the world of southern California’s biotechnology industry.
Revolutionizing Biotechnology with Exozymes: Michael Heltzen, CEO of Exozymes
Inside Biotech
1 hour 5 minutes 27 seconds
1 month ago
Revolutionizing Biotechnology with Exozymes: Michael Heltzen, CEO of Exozymes
Serial entrepreneur Michael Heltzen, CEO of Exozymes, reveals how his NASDAQ-listed company is "liberating enzymes from cells" to create a new generation of chemical manufacturing. Instead of using living cells as factories, Exozymes isolates enzymatic pathways to work as pure chemistry—achieving engineering-level control previously deemed impossible in conventional synthetic biology. Michael discusses Exozymes’ AI-powered enzyme evolution, six-week development timelines, bold IPO strategy during biotech's funding winter, and applications in pharmaceuticals like NCT for liver disease. This is synthetic biology's next chapter: sustainable, scalable enzyme-based manufacturing that could replace both petrochemicals and natural harvesting.
Make sure to check out eXoZymes' website: https://exozymes.com/
Inside Biotech
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside their companies to offer listeners diverse perspectives from experts across niches and levels in the biotech space. On Inside Biotech, science story-telling meets big business, touching on a range of themes from across the world of southern California’s biotechnology industry.
